两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000899140-19-000626 Act: 34 Size: 52 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012059 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012056 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012057 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012058 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012054 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-19-067235 Act: 34 Size: 569 KB 网页链接
$Onconova医疗(ONTX)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001104659-19-066848 Act: 33 Size: 326 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, item 8.01 Accession Number: 0001104659-19-066850 Act: 34 Size: 19 KB 网页链接
$Onconova医疗(ONTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-19-002636 Act: 33 Size: 1 KB 网页链接